Pharmaceutical composition comprising maple leaf extract for preventing or treating retinal disease
US11564962B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 11, 2017 |
| Grant date | Jan 31, 2023 |
| Priority date | — |
| Expiry date | Apr 10, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2250/21
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition comprising a maple leaf extract or fraction thereof for preventing or treating a retinal disease, a method for preventing or treating a retinal disease using the pharmaceutical composition, and a food composition comprising a maple leaf extract or fraction thereof for ameliorating the symptoms of a retinal disease.The pharmaceutical composition according to the present invention, which is effective for the treatment of a retinal disease, can be used pharmaceutically as a composition for preventing or treating a retinal disease, and can also be used advantageously as a health functional food.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.